Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization (Q57284581)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Natia Esiashvili

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

author name string

Stuart S Winter

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Kimberly P Dunsmore

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Meenakshi Devidas

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Brent L Wood

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Zhiguo Chen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Nancy Eisenberg

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Nikki Briegel

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Robert J Hayashi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Julie M Gastier-Foster

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Andrew J Carroll

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Barbara L Asselin

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Michael J Borowitz

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Mignon L Loh

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Karen R Rabin

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Elizabeth A Raetz

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Patrick A Zweidler-Mckay

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Naomi J Winick

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

William L Carroll

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Nyla A Heerema

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Paul S Gaynon

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Stephen P Hunger

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

language of work or name

0 references

publication date

23 August 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Journal of Clinical Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

2926-2934

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CNS leukemia: problem of diagnosis, treatment, and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling in T-cell acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic health conditions in adult survivors of childhood cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating childhood acute lymphoblastic leukemia without cranial irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric monitoring of residual disease in acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on biology and treatment of T-cell acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute Lymphoblastic Leukemia in Children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30138085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2018.77.7250

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30138085%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57284581&oldid=1567993148"